Boston, MA, United States of America

Soldano Ferrone

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Buffalo, NY (US) (2005 - 2012)
  • Pittsburg, PA (US) (2013)
  • Pittsburgh, PA (US) (2012 - 2014)
  • Boston, MA (US) (2015 - 2023)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Soldano Ferrone: A Pioneer in Cancer Research**

Introduction

Soldano Ferrone is a prominent inventor based in Boston, MA, known for his substantial contributions to cancer research. With an impressive portfolio of 27 patents, he has played a significant role in developing innovative therapies that target specific cancer cells, aiming to enhance treatment efficacy and patient outcomes.

Latest Patents

Among Ferrone's notable inventions are several groundbreaking patents that focus on chimeric antigen receptors (CAR) targeting chondroitin sulfate proteoglycan-4 (CSPG4). One of his latest patents, titled "CSGP4-specific chimeric antigen receptor for cancer," discloses methods and compositions related to CARs effective in inhibiting cancer cells expressing CSPG4. This innovative approach has shown promise in treating various forms of cancer, including melanoma, breast cancer, head and neck cancer, mesothelioma, glioblastoma, and renal cancer. Additionally, his patent on "Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof" outlines antibodies that bind to CSPG4, detailing methods for their use in the detection, prevention, and treatment of CSPG4-related diseases, particularly melanoma.

Career Highlights

Throughout his distinguished career, Soldano Ferrone has collaborated with esteemed institutions such as the University of Pittsburgh - of the Commonwealth System of Higher Education and The General Hospital Corporation. His work has intricately linked laboratory research with clinical applications, ultimately benefiting patients suffering from challenging cancers.

Collaborations

Ferrone has worked alongside notable colleagues, including Xinhui Wang and Elvira Favoino. Together, they have furthered advancements in cancer immunotherapy, focusing on targeted treatments that enhance the immune response against tumors.

Conclusion

Soldano Ferrone's contributions to cancer research through his innovative inventions and patents represent a significant step forward in medical science. His dedication to developing targeted immunotherapies showcases the potential of scientific research in transforming cancer treatment, providing hope for many patients battling this disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…